Prodotti della ricerca

 

UNICA IRIS Institutional Research Information System

IRIS è il sistema di gestione integrata dei dati della ricerca (persone, progetti, pubblicazioni, attività) adottato dall'Università degli Studi di Cagliari dal mese di luglio 2015.

Mostra risultati da 21 a 40 di 112
successivo >  < precedente 
TitoloData di pubblicazioneAutore(i)RivistaEditore
Caffeine potentiation of 3,4-methylenedioxymethamphetamine (MDMA) toxicity: role of age2011Frau L; Khairnar A; Fenu S; Morelli M
Possibile ruolo dei recettori 5-HT6 nelle dipendenze2011Gaetano Di Chiara; Valentina Valentini; Maria Antonietta De Luca; Sandro FenuITALIAN JOURNAL ON ADDICTION
CONDITIONED TASTE AVERSION ELICITED ERK ACTIVATION AND CHANGES OF DENDRITIC SPINES DENSITY: AN IMMUNOHISTOCHEMICAL, GOLGI-COX AND ELECTRON MICROSCOPY STUDY2011Acquas E; Vinci S; Fenu S; DeMontis MG; Gambarana C; Scheggi S; Falqui A; Marotta RBEHAVIOURAL PHARMACOLOGY
Effect of adenosine A1 and A2A antagonists on 3,4 methylenedioxymethamphetamine (MDMA)-induced neuroinflammation and dopamine neuron toxicity in mouse brain2011Khairnar A; Frau L; Fenu S; Plumitallo A; Morelli M
Possibile ruolo dei recettori 5-HT6 nelle dipendenze - Possible role of 5-HT6 receptors in addictions2011DI CHIARA G; VALENTINI V; DE LUCA MA; FENU SITALIAN JOURNAL ON ADDICTION
Behavioral and neurochemical pharmacology of 5-HT6 receptors related to reward and reinforcement2011Di Chiara G; Valentini V; Fenu SINTERNATIONAL REVIEW OF NEUROBIOLOGYElsevier
Disease modifying treatment with PPAR-gamma agonist rosiglitazone in a progressive mouse model of Parkinson's disease2010CARTA A; FENU S; FRAU L; IBBA M; WARDAS J; CABONI P; CARBONI ESOCIETY FOR NEUROSCIENCESociety for Neurosciences
Caffeine potentiates 3,4 methylenedioxymethamphetamine (MDMA, ecstasy)-induced-glial activation: role of age and adenosine A1 and A2A receptors2010Morelli M; Frau L; Khairnar A; Fenu SSOCIETY FOR NEUROSCIENCE
Controversie: Priming dopaminergico nel Parkinson. Il "priming" come modello sperimentale delle discinesie indotte da terapie dopaminergiche sostitutive nella Malattia di Parkinson2010Morelli M; Di Chiara G; Fenu S; Simola N; Carta AR
Role of Adenosine A1 and A2A receptors on 3,4-methylendioxymeth-amphetamine (MDMA, Ecstasy)-induced neurotoxicity, astroglia and microglia reactivity in mouse striatum and substantia nigra2010Khairnar A; Frau L; Fenu S; Morelli M
Conditioned saccharin avoidance and sensitization to drugs of abuse2010Fenu, S; Cadoni, C; Di Chiara, GBEHAVIOURAL BRAIN RESEARCH
Pharmacological therapy of Parkinson's disease: current options and new avenues2010Simola, N; Pinna, A; Fenu, SRECENT PATENTS ON CNS DRUG DISCOVERY
Differential involvement of dopamine D1 receptors in morphine- and lithium- conditioned saccharin avoidance2009FENU S; RIVAS E; DI CHIARA GPHYSIOLOGY & BEHAVIOR
Conditioned saccharin avoidance and sensitization to drugs of abuse2009Fenu S; Cadoni C; Di Chiara GBEHAVIOURAL PHARMACOLOGY
Reinforcing, rewarding and dopamine-stimulant properties of the 5-HT6 receptor agonist ST1936: the first member of a new class of psychostimulant?2009Di Chiara G; Valentini V; Fenu S; De Luca MA; Borsini FBEHAVIOURAL PHARMACOLOGY
REINFORCING, REWARDING AND DOPAMINE-STIMULANT PROPERTIES OF THE 5-HT6 RECEPTOR AGONIST ST1936: THE FIST MEMBER OF A NEW CLASS OF PSYCHOSTIMULANTS?2009G. DI CHIARA; V.VALENTINI; S.FENU; DE LUCA M; F. BORSINIBEHAVIOURAL PHARMACOLOGY
Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease2009FENU S; WARDAS J; MORELLI MBEHAVIOURAL PHARMACOLOGY
Effetto del blocco dei recettori oppioidi delta sul turning controlaterale indotto dagli agonisti dopaminergici in ratti lesionati con la 6-idrossidopamina2008Fenu S; Longoni R; Spina L; Di Chiara G
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D1 or D2 dopamine receptor agonists2008SIMOLA N; FENU S; BARALDI PG; TABRIZI MA; MORELLI MSYNAPSE
Different involvement of dopamine D1 receptor in morphine- and lithium-induced conditioned saccharin avoidance2007Fenu S; Rivas E; Di Chiara G
   
credits unica.it | accessibilità Università degli Studi di Cagliari
C.F.: 80019600925 - P.I.: 00443370929
note legali | privacy

Nascondi la toolbar